Fig. 2From: Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysisSummary (A) and graph (B) of the risk of bias in the included randomized controlled trials by the Cochrane risk of the bias assessment instrument. Assessments were based on the reviewers’ judgment of each domainBack to article page